Skip to main content

and
  1. Article

    Open Access

    Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer’s disease and frontotemporal dementia

    Loss of synaptic functionality has been recently identified as an early-stage indicator of neurological diseases. Consequently, monitoring changes in synaptic protein levels may be relevant for observing disea...

    Shreyasee Das, Julie Goossens, Dirk Jacobs, Nele Dewit in Alzheimer's Research & Therapy (2023)

  2. Article

    Open Access

    The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer’s disease

    Lack of early molecular biomarkers in sporadic behavioral variants of frontotemporal dementia (bvFTD) and its clinical overlap with primary psychiatric disorders (PPD) hampers its diagnostic distinction. Synap...

    Shreyasee Das, Marie-Paule E. van Engelen, Julie Goossens in Alzheimer's Research & Therapy (2024)